ESR1 and breast carcinoma: Despite not having a consistent molecular classification based on specific molecular markers (estrogen receptor, progesterone receptor, and HER2) like in breast cancer, canine mammary tumors can present germline mutations in BRCA1 and BRCA2 (40), important tumor suppressor genes inherited mutated in women breast tumors (41).